Petros Pharmaceuticals, Inc. Earnings Per Share (Basic)
Petros Pharmaceuticals, Inc. (PTPI) reported Earnings Per Share (Basic) of -$0.30 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-13
- Petros Pharmaceuticals, Inc. earnings per share, basic for the quarter ending 2026-06-30 was -$0.30.
- Petros Pharmaceuticals, Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$0.03.
- Petros Pharmaceuticals, Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$0.03.
- Petros Pharmaceuticals, Inc. earnings per share, basic for the quarter ending 2025-06-30 was -$1.20.
- Petros Pharmaceuticals, Inc. earnings per share, basic for fiscal 2025 was -$1.56.
- Petros Pharmaceuticals, Inc. earnings per share, basic for fiscal 2024 was -$83.47.
- Petros Pharmaceuticals, Inc. earnings per share, basic for fiscal 2023 was -$6.35.
- Petros Pharmaceuticals, Inc. earnings per share, basic for fiscal 2022 was -$9.68.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.30 10-Q · filed 2026-08-13 | -$0.33 10-Q · filed 2026-08-13 | ||||||
| 2026-03-31 | -$0.03 10-Q · filed 2026-05-13 | |||||||
| 2025-12-31 | -$1.56 10-K · filed 2026-04-15 | |||||||
| 2025-09-30 | -$0.03 10-Q · filed 2025-11-13 | -$1.95 10-Q · filed 2025-11-13 | ||||||
| 2025-06-30 | -$1.20 10-Q · filed 2026-08-13 | -$1.29 10-Q · filed 2025-08-14 | -$3.08 10-Q · filed 2026-08-13 | -$3.26 10-Q · filed 2025-08-14 | ||||
| 2025-03-31 | -$9.37 10-Q · filed 2026-05-13 | |||||||
| 2024-12-31 | -$26.68 derived: net income ÷ weighted average shares · filed 2026-04-15 | -$40.21 derived: net income ÷ weighted average shares · filed 2026-04-15 | -$51.52 derived: net income ÷ weighted average shares · filed 2026-04-15 | -$83.47 10-K · filed 2026-04-15 | -$3.34 10-K · filed 2025-03-31 | |||
| 2024-09-30 | -$16.65 10-Q · filed 2025-11-13 | -$0.53 10-Q · filed 2024-11-13 | -$23.18 derived: net income ÷ weighted average shares · filed 2025-11-13 | -$71.27 10-Q · filed 2025-11-13 | -$2.18 10-Q · filed 2024-11-13 | -$24.38 derived: net income ÷ weighted average shares · filed 2025-11-13 | ||
| 2024-06-30 | -$9.25 10-Q · filed 2025-08-14 | -$0.37 10-Q · filed 2024-08-14 | -$44.31 10-Q · filed 2025-08-14 | -$1.77 10-Q · filed 2024-08-14 | -$15.30 derived: net income ÷ weighted average shares · filed 2025-08-14 | -$16.57 derived: net income ÷ weighted average shares · filed 2025-08-14 | ||
| 2024-03-31 | -$42.19 10-Q · filed 2025-05-15 | -$1.69 10-Q · filed 2024-05-15 | -$9.24 derived: net income ÷ weighted average shares · filed 2025-05-15 | -$11.46 derived: net income ÷ weighted average shares · filed 2025-05-15 | ||||
| 2023-12-31 | -$1.61 derived: net income ÷ weighted average shares · filed 2025-03-31 | -$4.39 derived: net income ÷ weighted average shares · filed 2025-03-31 | -$6.35 10-K · filed 2025-03-31 | |||||
| 2023-09-30 | -$2.85 10-Q · filed 2024-11-13 | -$2.31 10-Q · filed 2023-11-15 | -$4.73 10-Q · filed 2024-11-13 | -$4.18 10-Q · filed 2023-11-15 | ||||
| 2023-06-30 | -$1.20 10-Q · filed 2024-08-14 | -$1.87 10-Q · filed 2024-08-14 | ||||||
| 2023-03-31 | -$0.66 10-Q · filed 2024-05-15 | -$2.69 derived: net income ÷ weighted average shares · filed 2024-05-15 | -$9.36 derived: net income ÷ weighted average shares · filed 2024-05-15 | |||||
| 2022-12-31 | -$2.03 derived: net income ÷ weighted average shares · filed 2024-04-01 | -$8.71 derived: net income ÷ weighted average shares · filed 2024-04-01 | -$9.68 10-K · filed 2024-04-01 | |||||
| 2022-09-30 | -$6.69 10-Q · filed 2023-11-15 | -$0.67 10-Q · filed 2022-11-14 | -$7.65 10-Q · filed 2023-11-15 | -$0.76 10-Q · filed 2022-11-14 | ||||
| 2022-06-30 | -$0.88 10-Q · filed 2023-08-14 | -$0.09 10-Q · filed 2022-08-12 | -$0.96 10-Q · filed 2023-08-14 | -$0.10 10-Q · filed 2022-08-12 | ||||
| 2022-03-31 | -$0.08 10-Q · filed 2023-05-15 | -$0.01 10-Q · filed 2022-05-16 | ||||||
| 2021-12-31 | -$8.25 10-K · filed 2023-03-31 | -$0.83 10-K · filed 2022-03-31 | ||||||
| 2021-09-30 | -$0.17 10-Q/A · filed 2022-11-15 | -$0.08 10-Q/A · filed 2022-11-15 | ||||||
| 2021-06-30 | -$0.22 10-Q · filed 2022-08-12 | $0.09 10-Q · filed 2022-08-12 | ||||||
| 2021-03-31 | $0.31 10-Q · filed 2022-05-16 | |||||||
| 2020-12-31 | -$3.85 10-K · filed 2022-03-31 | |||||||
| 2020-09-30 | -$0.96 10-Q · filed 2021-11-15 | -$4.41 10-Q · filed 2021-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B |